FI933802A7 - Oxazolidinderivat med egenskaper som motverkar sockersjuka och fetma, deras framstaellning och deras terapeutiska anvaendningar - Google Patents

Oxazolidinderivat med egenskaper som motverkar sockersjuka och fetma, deras framstaellning och deras terapeutiska anvaendningar Download PDF

Info

Publication number
FI933802A7
FI933802A7 FI933802A FI933802A FI933802A7 FI 933802 A7 FI933802 A7 FI 933802A7 FI 933802 A FI933802 A FI 933802A FI 933802 A FI933802 A FI 933802A FI 933802 A7 FI933802 A7 FI 933802A7
Authority
FI
Finland
Prior art keywords
och
deras
sockersjuka
motverkar
fetma
Prior art date
Application number
FI933802A
Other languages
English (en)
Finnish (fi)
Other versions
FI933802A0 (fi
Inventor
Takashi Fujita
Takao Yoshioka
Shinji Yoshioka
Toshihiko Fujiwara
Hiroyoshi Horikoshi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of FI933802A0 publication Critical patent/FI933802A0/fi
Publication of FI933802A7 publication Critical patent/FI933802A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI933802A 1992-08-31 1993-08-31 Oxazolidinderivat med egenskaper som motverkar sockersjuka och fetma, deras framstaellning och deras terapeutiska anvaendningar FI933802A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23114092 1992-08-31

Publications (2)

Publication Number Publication Date
FI933802A0 FI933802A0 (fi) 1993-08-31
FI933802A7 true FI933802A7 (fi) 1994-03-01

Family

ID=16918916

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933802A FI933802A7 (fi) 1992-08-31 1993-08-31 Oxazolidinderivat med egenskaper som motverkar sockersjuka och fetma, deras framstaellning och deras terapeutiska anvaendningar

Country Status (21)

Country Link
US (1) US5436257A (da)
EP (1) EP0590793B1 (da)
JP (1) JP3201891B2 (da)
KR (1) KR940003955A (da)
CN (1) CN1036588C (da)
AT (1) ATE185564T1 (da)
AU (1) AU663611B2 (da)
CA (1) CA2105149A1 (da)
CZ (1) CZ287027B6 (da)
DE (1) DE69326736T2 (da)
DK (1) DK0590793T3 (da)
ES (1) ES2139633T3 (da)
FI (1) FI933802A7 (da)
GR (1) GR3031887T3 (da)
HU (1) HUT67087A (da)
IL (1) IL106839A (da)
NO (1) NO302121B1 (da)
NZ (1) NZ248532A (da)
RU (1) RU2090564C1 (da)
TW (1) TW318181B (da)
ZA (1) ZA936324B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
NO303782B1 (no) * 1994-03-23 1998-08-31 Sankyo Co Tiazolidin- og oksazolidinderivater og farmas°ytiske preparater inneholdende slike, samt deres anvendelse til fremstilling av medikamenter
NO305987B1 (no) * 1994-04-11 1999-08-30 Sankyo Co Heterosykliske forbindelser med antidiabetisk aktivitet, deres anvendelse og farmasoeytisk preparat inneholdende disse
SK111195A3 (en) * 1994-09-13 1997-06-04 Sandoz Technology Ltd Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same
JPH09136877A (ja) * 1995-06-16 1997-05-27 Takeda Chem Ind Ltd 複素環化合物、その製造法及び用途
EP0783888A1 (en) 1995-12-26 1997-07-16 Sankyo Company Limited Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
TW399051B (en) * 1996-01-31 2000-07-21 Ssp Co Ltd A novel benzoazine thiazolidinedione derivative and pharmaceutical composition for reducing blood glucose
ZA973848B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them.
US5919782A (en) * 1996-05-06 1999-07-06 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
US5801173A (en) * 1996-05-06 1998-09-01 Dr. Reddy's Research Foundation Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
ZA973850B (en) * 1996-05-06 1997-12-02 Reddy Research Foundation Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them.
AU744518B2 (en) 1996-07-01 2002-02-28 Dr. Reddy's Laboratories Limited Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6114526A (en) * 1996-07-01 2000-09-05 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US6372750B2 (en) 1996-07-01 2002-04-16 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases
USRE39266E1 (en) 1996-07-01 2006-09-05 Dr. Reddy's Laboratories, Limited Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
US5885997A (en) * 1996-07-01 1999-03-23 Dr. Reddy's Research Foundation Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
JP2000514041A (ja) * 1996-07-26 2000-10-24 ドクター・レディーズ・リサーチ・ファウンデーション 抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物
IN187716B (da) * 1998-09-14 2002-06-15 Reddy Research Foundation
US7407978B2 (en) * 1999-04-06 2008-08-05 Theracos, Inc. Heterocyclic analogs of diphenylethylene compounds
US6525202B2 (en) 2000-07-17 2003-02-25 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
US6465501B2 (en) 2000-07-17 2002-10-15 Wyeth Azolidines as β3 adrenergic receptor agonists
US6410734B1 (en) 2000-07-17 2002-06-25 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
US6537994B2 (en) 2000-07-17 2003-03-25 Wyeth Heterocyclic β3 adrenergic receptor agonists
US6498170B2 (en) 2000-07-17 2002-12-24 Wyeth Cyclamine sulfonamides as β-3 adrenergic receptor agonists
US6794401B2 (en) * 2003-01-17 2004-09-21 Bexel Pharmaceuticals, Inc. Amino acid phenoxy ethers
WO2006041921A2 (en) * 2004-10-05 2006-04-20 Auspex Pharmaceuticals, Inc. Preparation and uses of rhodanine derivatives
JP5732453B2 (ja) 2009-06-25 2015-06-10 アルカーメス ファーマ アイルランド リミテッド Ｎｈ酸性化合物のプロドラッグ
ES2394349B1 (es) 2012-08-29 2013-11-04 Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii Uso de agonistas selectivos de receptores beta-3 adrenérgicos para el tratamiento de hipertensión pulmonar
AU2019230014B2 (en) 2018-03-05 2024-11-28 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN115433144B (zh) * 2022-10-09 2023-09-19 燃点(南京)生物医药科技有限公司 一种脂肪酸酯类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
JPS6242903A (ja) 1985-08-16 1987-02-24 Earth Chem Corp Ltd ハエ誘引剤
HU203330B (en) 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
EP0295828A1 (en) * 1987-06-13 1988-12-21 Beecham Group Plc Novel compounds
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
JPH0231079A (ja) 1988-07-20 1990-02-01 Kubota Ltd 作業車の変速操作構造
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
US5143930A (en) 1990-02-07 1992-09-01 Sankyo Company, Limited Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
US5037842A (en) * 1990-06-05 1991-08-06 Pfizer Inc. Oxa- and thiazolidinedione hypoglycemic and hypocholesterolemic agents
GB9023583D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds
GB9023584D0 (en) * 1990-10-30 1990-12-12 Beecham Group Plc Novel compounds

Also Published As

Publication number Publication date
DK0590793T3 (da) 2000-01-31
CZ176393A3 (en) 1994-04-13
NO933080L (no) 1994-03-01
DE69326736T2 (de) 2000-06-08
EP0590793A1 (en) 1994-04-06
ES2139633T3 (es) 2000-02-16
CZ287027B6 (en) 2000-08-16
AU4496593A (en) 1994-03-10
IL106839A0 (en) 1993-12-08
CN1036588C (zh) 1997-12-03
RU2090564C1 (ru) 1997-09-20
JPH06157522A (ja) 1994-06-03
GR3031887T3 (en) 2000-02-29
US5436257A (en) 1995-07-25
ZA936324B (en) 1994-03-22
TW318181B (da) 1997-10-21
ATE185564T1 (de) 1999-10-15
KR940003955A (ko) 1994-03-14
CA2105149A1 (en) 1994-03-01
AU663611B2 (en) 1995-10-12
HU9302449D0 (en) 1993-11-29
JP3201891B2 (ja) 2001-08-27
HUT67087A (en) 1995-01-30
NO933080D0 (no) 1993-08-30
FI933802A0 (fi) 1993-08-31
HK1011979A1 (en) 1999-07-23
DE69326736D1 (de) 1999-11-18
NZ248532A (en) 1995-04-27
EP0590793B1 (en) 1999-10-13
IL106839A (en) 1998-02-22
NO302121B1 (no) 1998-01-26
CN1090281A (zh) 1994-08-03

Similar Documents

Publication Publication Date Title
FI925255L (fi) Aromatiska amino-alkoholderivat med egenskaper som motverkar sockersjuka och fetma, deras framstaellning och terapeutiska anvaendningar
FI932961L (fi) Metallocener med arylsubsituerade indenylderivat som ligander, foerfarande foer framstaellning av dessa och anvaendning av dessa som katalysatorer
FI932402A7 (fi) Foerfarande och anordning foer saendning, mottagning och oeverfoering av datasignaler med motsvarande programdatasignaler
DE59108494D1 (de) 1-H-3-Aryl-pyrrolidin-2,4-dion-Derivate
FI930970A7 (fi) Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa
FI925926L (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
FI910256L (fi) Foerfarande foer bestaemning av mikrobpatogener, som sprids med vatten, och fekala foeroreningar indikerande aemnen i vattenprov och testfoerpackning.
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI933472A7 (fi) Peptider med foermaoga att inhibera effekten av HIV-proteas, deras framstaellning och terapeutiska anvaendning
FI925924L (fi) Hydrerat staerkelsehydrolysat med laog kariesframkallande effekt, foerfarande foer framstaellning av detta och tillaempningen av detta hydrolysat
FI911980L (fi) N-(3-fluor-2-fosfonylmetoxipropyl) -derivat av heterocykliska purin- och pyrimidinbaser, deras framstaellning och anvaendning.
FI922983L (fi) Pyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
FI922875L (fi) Foereningar med reninhaemmande egenskaper, foerfarande foer deras framstaellning och deras anvaendning
FI910163A7 (fi) Kilsinkningsfraesanordning och foerfarande som utfoers med hjaelp av denna.
FI914487L (fi) 1,3-bensoxazinderivat, deras framstaellning och anvaendning.
FI915626L (fi) Magnesiumkloridpartiklar med polyederstruktur, katalytisk komposant med dessa partiklar som baerare och olefiner, som faotts med hjaelp av denna katalytiska komposant.
FI913201A7 (fi) Ymppolysackarider, deras framställningsförfarande och deras användning som sekvesteringsagenter
FI934589L (fi) Rikligt med vatten absorberat ris, foerfarande foer framstaellning av detta och anvaendning av detta
FI913067L (fi) Bisfosfonsyraderivat, deras framstaellning och anvaendning.
FI922982L (fi) 2-aminopyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa
FI913674A0 (fi) Med textilbaerband och sprutpressat spaerrorgan foersedd dragked och foerfarande foer framstaellning av en dylik dragked.
FI930264A7 (fi) 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxokinolinderivat saosom antihyperkolesterolemiska och antiaterosklerotiska medel
FI924030L (fi) Sportsko, saerskilt en skidkaenga med vridningsstyvande och boejningsfjaedrande medel
FI923841A7 (fi) Substituerade mandelsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel